BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 23408844)

  • 1. Genetic damage in patients with chronic kidney disease, peritoneal dialysis and haemodialysis: a comparative study.
    Rangel-López A; Paniagua-Medina ME; Urbán-Reyes M; Cortes-Arredondo M; Alvarez-Aguilar C; López-Meza J; Ochoa-Zarzosa A; Lindholm B; García-López E; Paniagua JR
    Mutagenesis; 2013 Mar; 28(2):219-25. PubMed ID: 23408844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic damage and circulating AGE levels in patients undergoing daily versus standard haemodialysis.
    Fragedaki E; Nebel M; Schupp N; Sebekova K; Völkel W; Klassen A; Pischetsrieder M; Frischmann M; Niwa T; Vienken J; Heidland A; Stopper H
    Nephrol Dial Transplant; 2005 Sep; 20(9):1936-43. PubMed ID: 15919695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative DNA damage and mortality in hemodialysis and peritoneal dialysis patients.
    Xu H; Watanabe M; Qureshi AR; Heimbürger O; Bárány P; Anderstam B; Eriksson M; Stenvinkel P; Lindholm B
    Perit Dial Int; 2015; 35(2):206-15. PubMed ID: 24584621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation Between the 8-hydroxy-2'-deoxyguanosine Level in the Peritoneal Solution of Patients Undergoing Peritoneal Dialysis and the Peritoneal Equilibration Test, Kt/V, Ferritin, and Albumin Levels.
    Khanifar H; Mahmoodnia L
    Iran J Kidney Dis; 2024 Mar; 18(2):118-123. PubMed ID: 38660699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation and oxidative stress in end-stage renal disease patients treated with hemodialysis or peritoneal dialysis.
    Filiopoulos V; Hadjiyannakos D; Takouli L; Metaxaki P; Sideris V; Vlassopoulos D
    Int J Artif Organs; 2009 Dec; 32(12):872-82. PubMed ID: 20037892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased oxidative damage to peripheral blood leukocyte DNA in chronic peritoneal dialysis patients.
    Tarng DC; Wen Chen T; Huang TP; Chen CL; Liu TY; Wei YH
    J Am Soc Nephrol; 2002 May; 13(5):1321-30. PubMed ID: 11961020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum 8-hydroxydeoxyguanosine, a marker of oxidative DNA damage, is associated with mortality independent of inflammation in chronic kidney disease.
    Dai L; Watanabe M; Qureshi AR; Mukai H; Machowska A; Heimbürger O; Barany P; Lindholm B; Stenvinkel P
    Eur J Intern Med; 2019 Oct; 68():60-65. PubMed ID: 31402276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-glucans in advanced CKD: role in endotoxaemia and inflammation.
    Wong J; Zhang Y; Swift O; Finkelman M; Patidar A; Ramanarayanan S; Vilar E; Farrington K
    BMC Nephrol; 2020 Apr; 21(1):118. PubMed ID: 32252666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of advanced glycation end products accumulation, using skin autofluorescence, in CKD and dialysis patients.
    Oleniuc M; Schiller A; Secara I; Onofriescu M; Hogas S; Apetrii M; Siriopol D; Covic A
    Int Urol Nephrol; 2012 Oct; 44(5):1441-9. PubMed ID: 22160646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unfermented grape juice reduce genomic damage on patients undergoing hemodialysis.
    Corredor Z; Rodríguez-Ribera L; Coll E; Montañés R; Diaz JM; Ballarin J; Marcos R; Pastor S
    Food Chem Toxicol; 2016 Jun; 92():1-7. PubMed ID: 27016493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accelerated atherosclerosis in haemodialysis patients; correlation of endothelial function with oxidative DNA damage.
    Kaya Y; Ari E; Demir H; Soylemez N; Cebi A; Alp H; Bakan E; Gecit I; Asicioglu E; Beytur A
    Nephrol Dial Transplant; 2012 Mar; 27(3):1164-9. PubMed ID: 21821836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 8-hydroxy-2'-deoxyguanosine of leukocyte DNA as a marker of oxidative stress in chronic hemodialysis patients.
    Tarng DC; Huang TP; Wei YH; Liu TY; Chen HW; Wen Chen T; Yang WC
    Am J Kidney Dis; 2000 Nov; 36(5):934-44. PubMed ID: 11054349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma S100A12 and soluble receptor of advanced glycation end product levels and mortality in chronic kidney disease Stage 5 patients.
    Isoyama N; Leurs P; Qureshi AR; Bruchfeld A; Anderstam B; Heimburger O; Bárány P; Stenvinkel P; Lindholm B
    Nephrol Dial Transplant; 2015 Jan; 30(1):84-91. PubMed ID: 25074436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein oxidative stress and dyslipidemia in dialysis patients.
    Marques de Mattos A; Marino LV; Ovidio PP; Jordão AA; Almeida CC; Chiarello PG
    Ther Apher Dial; 2012 Feb; 16(1):68-74. PubMed ID: 22248198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of oxidative stress and cellular inflammation in patients with diabetic nephropathy and non-diabetic nephropathy being administered hemodialysis treatment due to chronic renal failure.
    Avci E; Cakir E; Cevher SC; Yaman H; Agilli M; Bilgi C
    Ren Fail; 2014 Jun; 36(5):767-73. PubMed ID: 24579657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic damage as a biomarker of chronic kidney disease status.
    Corredor Z; Stoyanova E; Rodríguez-Ribera L; Coll E; Silva I; Diaz JM; Ballarin J; Marcos R; Pastor S
    Environ Mol Mutagen; 2015 Apr; 56(3):301-12. PubMed ID: 25234591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of serum lncRNA H19 expression with inflammatory and oxidative stress markers and routine biochemical parameters in chronic kidney disease.
    Okuyan HM; Dogan S; Terzi MY; Begen MA; Turgut FH
    Clin Exp Nephrol; 2021 May; 25(5):522-530. PubMed ID: 33548016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma Pentosidine and Its Association with Mortality in Patients with Chronic Kidney Disease.
    Machowska A; Sun J; Qureshi AR; Isoyama N; Leurs P; Anderstam B; Heimburger O; Barany P; Stenvinkel P; Lindholm B
    PLoS One; 2016; 11(10):e0163826. PubMed ID: 27701453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between volume overload, chronic inflammation, and left ventricular dysfunction in chronic kidney disease patients.
    Hassan MO; Duarte R; Dix-Peek T; Vachiat A; Naidoo S; Dickens C; Grinter S; Manga P; Naicker S
    Clin Nephrol; 2016 Supplement 1; 86 (2016)(13):131-135. PubMed ID: 27509588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients receiving maintenance dialysis have more severe functionally significant skeletal muscle wasting than patients with dialysis-independent chronic kidney disease.
    McIntyre CW; Selby NM; Sigrist M; Pearce LE; Mercer TH; Naish PF
    Nephrol Dial Transplant; 2006 Aug; 21(8):2210-6. PubMed ID: 16504974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.